← FDA ENFORCEMENT
D-0005-2025Class I
Gilead Sciences, Inc.
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Gilead Sciences, Inc.
Product type
Drug
Status
Terminated
Report date
2024-10-09
Distribution
Nationwide in the U.S.A.
Firm state
CA
Product quantity
105,000 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
Presence of Particulate Matter: Presence of glass particle.
Product description
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Code / lot info
Lot: 47035CFA, Exp. 11/2025
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →